Filing Details

Accession Number:
0001562180-22-007754
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-17 20:37:20
Reporting Period:
2022-11-15
Accepted Time:
2022-11-17 20:37:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404123 1Life Healthcare Inc ONEM Services-Offices & Clinics Of Doctors Of Medicine (8011) 760707204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800511 A Lisa Mango C/O 1Life Healthcare, Inc.
One Embarcadero Center, Suite 1900
San Francisco CA 94111
General Counsel And Secretary No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-15 2,472 $12.16 90,857 No 4 M Direct
Common Stock Disposition 2022-11-15 2,472 $16.84 88,385 No 4 S Direct
Common Stock Acquisiton 2022-11-15 8,542 $0.00 96,927 No 4 M Direct
Common Stock Disposition 2022-11-16 4,230 $16.82 92,697 No 4 S Direct
Common Stock Disposition 2022-11-17 4,312 $16.71 88,385 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-11-15 2,472 $0.00 2,472 $12.16
Common Stock Restricted Stock Units Disposition 2022-11-15 8,542 $0.00 8,542 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
93,948 2032-01-14 No 4 M Direct
25,627 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
  2. This transaction was executed in multiple trades at prices ranging from $16.805 to $16.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis.
  4. Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
  5. This transaction was executed in multiple trades at prices ranging from $16.81 to $16.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $16.68 to $16.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to reporting person's continuous service as of each such date.
  8. The restricted stock units will vest annually over three years, with 25% of the restricted stock units vesting on each of the first and second anniversaries of the vesting commencement date and 50% of the restricted stock units vesting on the third anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.